Back to top

genomics: Archive

Sundeep Ganoria

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

CRSP bets on Casgevy to drive growth, but its extremely high price tag and slow rollout test investor patience in a crowded field.

NVSNegative Net Change BMYNegative Net Change VRTXNegative Net Change BEAMNegative Net Change CRSPNegative Net Change